Clinical Trial Update: Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of enteric-coated mycophenolate sodium (EC-MPS) plus valsartan in de novo kidney transplant patients has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: De Novo Renal Transplantation | Phase 3 | Status: COMPLETED